Core Points - Emergent BioSolutions announced the retirement of Dr. Louis W. Sullivan from its Board of Directors effective November 14, after 19 years of service [1][2] - Dr. Sullivan has been a significant figure in guiding the company through critical decisions, particularly during its multi-year transformation [2] - The company has a mission focused on protecting and saving lives, providing solutions for various health threats [3] Company Overview - Emergent BioSolutions has been operational for over 25 years, preparing for public health challenges and delivering life-saving solutions against threats like smallpox, mpox, botulism, Ebola, anthrax, and opioid overdose emergencies [3] - The company emphasizes its commitment to public health and community preparedness for current and future health threats [3] Leadership Transition - Dr. Sullivan served on the Board since 2006, holding roles such as chair of the compensation committee and member of the nominating and corporate governance committee [2] - His background includes leadership positions in healthcare and government, notably as president of Morehouse School of Medicine and Secretary of the Department of Health and Human Services [2]
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors